Gene-Eden-VIR is Antiviral; New Clinical Study by the CBCD Published in Pharmacology & Pharmacy

Share Article

The Center for the Biology of Chronic Disease (CBCD) points out a new clinical study published on August 21, 2013 in the medical journal Pharmacology & Pharmacy. The study “showed that the natural product Gene-Eden-VIR safely and effectively decreases symptoms in individuals infected with the HPV, HSV, EBV, HCMV, and HCV (1).”

News Image
Like everyone else, had my doubts about the effectiveness of this natural product. When I first saw the statistical results, I was amazed. - Edan Itzkovitz, Study Author, CBCD

The mission of the CBCD is to advance research on the biology of foreign DNA, and accelerate the discovery of a cure for diseases caused by foreign DNA. The CBCD is excited about Gene-Eden-VIR since it fits this mission. It targets latent viruses, and therefore, decreases the foreign DNA in infected individuals.

Therefore, when polyDNA turned to the CBCD, the Center was more than happy to conduct a clinical study on Gene-Eden-VIR. The results of the study were published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs.

The results of the study showed that Gene-Eden-VIR “is a safe and effective treatment against the Human Papillomavirus (HPV), Herpes Simplex Virus (HSV), Epstein Barr Virus (EBV), Human Cytomegalovirus (HCMV), and Hepatitis C Virus (HCV) (1).”

This study is unique in the natural, dietary supplement market. Most sellers of dietary supplements do not conduct clinical studies to test the effectiveness of their products since “the law does not consider dietary supplements as drugs, and therefore, does not require the FDA to evaluate the effectiveness of these supplements (1).”

This is one of the first times that a research paper was published in a peer reviewed journal reporting a clinical study on a proprietary, patent protected, natural formula.

The CBCD is very excited about the results of this study since as far as the Center knows, Gene-Eden-VIR is the only treatment capable of decreasing the concentration of latent viruses in infected individuals. Since the CBCD believes in Dr. Polansky’s theory that identifies latent viruses as the cause of most major diseases, the Center sees Gene-Eden-VIR as an important first step towards a cure.

One of the study authors, Edan Itzkovitz, said “I was so surprised to discover that a natural product could have such a significant effect. Everybody knows that natural products are safe. But I, like everyone else, had my doubts about the effectiveness of this natural product. When I first saw the statistical results, I was amazed. It’s really a remarkable product, and I’m happy to have been part of the study.”

To view the entire paper, visit: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

The CBCD invites the media to contact the Center for interviews at: info AT cbcd DOT com or phone 585-250-9999.

###

References:

(1)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Hanan Polansky
Center for the Biology of Chronic Disease (CBCD)
+1 (585) 250-9999
Email >
Visit website